Sarcopenic obesity in ageing: cardiovascular outcomes and mortality
The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
Obesity is a major public health issue with prevalence increasing worldwide. Obesity is a well-established risk factor for CVD and mortality in adult populations. However, the impact of being overweight or obese in the elderly on CVD and mortality is controversial. Some studies even suggest that overweight and obesity, measured by BMI, are apparently associated with a decreased mortality risk (known as the obesity paradox). Ageing is associated with an increase in visceral fat and a progressive loss of muscle mass. Fat mass is positively associated and lean mass is negatively associated with risk of mortality. Therefore, in older adults BMI is not a good indicator of obesity. Sarcopenia has been defined as the degenerative loss of muscle mass, quality and strength with age and is of major concern in ageing populations. Sarcopenia has previously been associated with increased risks of metabolic impairment, cardiovascular risk factors, physical disability and mortality. It is possible for sarcopenia to co-exist with obesity, and sarcopenic obesity is a new class of obesity in older adults who have high adiposity levels together with low muscle mass, quality or strength. Therefore, sarcopenia with obesity may act together to increase their effect on metabolic disorders, CVD and mortality. This review will discuss the available evidence for the health implications of sarcopenic obesity on CVD and mortality in older adults.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sarcopenic obesity significantly increases the risk of cardiovascular risk factors including insulin resistance (IR), metabolic syndrome, and adverse glycolipid metabolism (16, 42–44), even in the context of divergent comorbidities such as cancer and peritoneal dialysis (45, 46).”
From Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management (2023) · cites this paper as [42]
In the citing paper
“Sarcopenic obesity has been so far identified through various definitions and diagnostic constructs, but it has been consistently demonstrated to be a strong and independent risk factor for frailty, comorbidities and mortality in various highly prevalent disease conditions, as well as for mortality in the general and especially in the older population [17-19].”
From Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement (2022) · cites this paper as [18]
In the citing paper
“Nevertheless, up to 8-fold increased risk of metabolic syndrome in individuals classified as having sarcopenic obesity has been reported along with increased risk for other cardiovascular/metabolic diseases (14).”
From Body composition in male lifelong trained strength, sprint and endurance athletes and healthy age-matched controls (2023) · cites this paper as [14]
In the citing paper
“It is important to remember that sarcopenic obesity can occur at any age, and that excess fat and low muscle mass may act synergistically to influence daily physical activity/energy expenditure and increase the risk of cardiovascular comorbidities across adulthood and subsequently premature mortality (14).”
From Body composition in male lifelong trained strength, sprint and endurance athletes and healthy age-matched controls (2023) · cites this paper as [14]
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601 · cited 2×
“In 2010, The European Working Group on Sarcopenia in Older People (EWGSOP) published a sarcopenia definition to assist in case finding in older adults(49).”
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Levesque, R. J. R. (2017) · Encyclopedia of Adolescence · doi:10.1007/978-3-319-32132-5_447-2 · Cited by 4,021
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 1×
“Sarcopenia was originally defined by Baumgartner et al.(19) as appendicular skeletal muscle mass two SD below”
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Janssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139 · cited 1×
“Janssen et al.(48) developed an alternative sarcopenia definition of skeletal muscle mass measured by BIA.”
The Epidemiology of Obesity: A Big Picture
Hruby, A., & Hu, F. B. (2015) · PharmacoEconomics · doi:10.1007/s40273-014-0243-x · Cited by 2,916
Studenski, S. A., Peters, K. W., Alley, D. E., Cawthon, P. M., McLean, R. R., Harris, T. B., Ferrucci, L., Guralnik, J. M., Fragala, M. S., Kenny, A. M., et al. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu010 · Cited by 2,545 · cited 1×
“In 2014, an alternative and more specific sarcopenia definition was recommended by the Foundation for the National Institutes of Health Sarcopenia Project; appendicular lean mass cut-points adjusted for BMI (<0·789 for men;<0·512 for women) and for grip strength cut-points (<26 kg for men; <16 kg for women)(50).”
Prentice, A. M., & Jebb, S. A. (2001) · Obesity Reviews · doi:10.1046/j.1467-789x.2001.00031.x · Cited by 1,240
The Emerging Risk Factors Collaboration (2011) · The Lancet · doi:10.1016/s0140-6736(11)60105-0 · Cited by 1,216 · cited 1×
“Obesity is a well-established risk factor for CVD and mortality in adult populations (7 – 10) ; typically ‘ U ’ or ‘ J ’ shaped curves are seen between obesity (measured by BMI) and CVD or mortality, with increased risks in underweight and overweight middle-aged adults.”
Houston, D. K., Nicklas, B. J., Ding, J., Harris, T. B., Tylavsky, F. A., Newman, A. B., Lee, J. S., Sahyoun, N. R., Visser, M., & Kritchevsky, S. B. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.150 · Cited by 1,214
Body Composition in Healthy Aging
BAUMGARTNER, R. N. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06498.x · Cited by 1,078 · cited 3×
“The term ‘sarcopenic obesity’ was first coined by Baumgartner(41) and combines the body composition categories of both sarcopenia and obesity.”
Influentialde Koning, L., Merchant, A. T., Pogue, J., & Anand, S. S. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm026 · Cited by 1,073
Sarcopenic obesity: definition, cause and consequences
Stenholm, S., Harris, T. B., Rantanen, T., Visser, M., Kritchevsky, S. B., & Ferrucci, L. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328312c37d · Cited by 1,070
Welcome to the ICD‐10 code for sarcopenia
Anker, S. D., Morley, J. E., & von Haehling, S. (2016) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12147 · Cited by 983
Sarcopenic obesity: A new category of obesity in the elderly
Zamboni, M., Mazzali, G., Fantin, F., Rossi, A., & Di Francesco, V. (2008) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.10.002 · Cited by 953 · cited 1×
“Sarcopenic obesity has recently emerged as a new category of body composition(6) (Fig.”
Sarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly
Baumgartner, R. N., Wayne, S. J., Waters, D. L., Janssen, I., Gallagher, D., & Morley, J. E. (2004) · Obesity Research · doi:10.1038/oby.2004.250 · Cited by 937
Morley, J. E., Baumgartner, R. N., Roubenoff, R., Mayer, J., & Nair, K. S. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.113504 · Cited by 936
Kalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882
BMI and all-cause mortality in older adults: a meta-analysis
Winter, J. E., MacInnis, R. J., Wattanapenpaiboon, N., & Nowson, C. A. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.068122 · Cited by 790
Celis-Morales, C. A., Welsh, P., Lyall, D. M., Steell, L., Petermann, F., Anderson, J., Iliodromiti, S., Sillars, A., Graham, N., Mackay, D. F., et al. (2018) · BMJ · doi:10.1136/bmj.k1651 · Cited by 772
Bogers, R. P. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.16.1720 · Cited by 656
Health consequences of obesity in the elderly: a review of four unresolved questions
Zamboni, M., Mazzali, G., Zoico, E., Harris, T. B., Meigs, J. B., Di Francesco, V, Fantin, F., Bissoli, L., & Bosello, O. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803005 · Cited by 649
Muscle strength and body mass index as long-term predictors of mortality in initially healthy men
Rantanen, T., Harris, T., Leveille, S. G., Visser, M., Foley, D., Masaki, K., & Guralnik, J. M. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.3.m168 · Cited by 647 · cited 3×
“The pooled HR showed that sarcopenic obesity was associated with a 21 % increase in risk of all-cause mortality compared with the non-sarcopenic, non-obese group (14% increase in community-dwelling older people and 65 % increase in hospitalised patients) Rantanen et al. (88) Prospective cohort (30-year (90) Prospectiv…”
Srikanthan, P., Hevener, A. L., & Karlamangla, A. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010805 · Cited by 600
Sarcopenic obesity and inflammation in the InCHIANTI study
Schrager, M. A., Metter, E. J., Simonsick, E., Ble, A., Bandinelli, S., Lauretani, F., & Ferrucci, L. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00627.2006 · Cited by 594 · cited 2×
“Chianti’ (InCHIANTI) study of older adults, aged 65 years and older, showed that sarcopenic obesity (defined using grip strength andwaist circumferencemeasurements) was associated with higher levels of inflammatory markers including IL-6 and C-reactive protein in cross-sectional analysis(72).”
Sarcopenic obesity: a critical appraisal of the current evidence
Prado, C. M. M., Wells, J. C. K., Smith, S. R., Stephan, B. C. M., & Siervo, M. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.06.010 · Cited by 589 · cited 1×
“In spite of the growth of literature on the associations between sarcopenic obesity and cardiovascular risk factors in recent years, to date only a limited number of studies have assessed the associations between sarcopenic obesity and CVD risk in older adults (35,39,57,77) .”
Lim, S., Kim, J. H., Yoon, J. W., Kang, S. M., Choi, S. H., Park, Y. J., Kim, K. W., Lim, J. Y., Park, K. S., & Jang, H. C. (2010) · Diabetes Care · doi:10.2337/dc10-0107 · Cited by 588
Enzi, G., Gasparo, M., Biondetti, P., Fiore, D., Semisa, M., & Zurlo, F. (1986) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/44.6.739 · Cited by 547 · cited 1×
“As people age, some important changes to body composition occur, which includes a relative increase in visceral abdominal fat and a gradual loss of muscle mass (14 – 16) .”
Atkins, J. L., Whincup, P. H., Morris, R. W., Lennon, L. T., Papacosta, O., & Wannamethee, S. G. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12652 · Cited by 509
Self-citationBatsis, J. A., Mackenzie, T. A., Barre, L. K., Lopez-Jimenez, F., & Bartels, S. J. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.117 · Cited by 479 · cited 4×
“However, there was no significant increase in mortality risk in sarcopenic obese men in this cohort(85).”
InfluentialSarcopenic Obesity: The Confluence of Two Epidemics
Roubenoff, R. (2004) · Obesity Research · doi:10.1038/oby.2004.107 · Cited by 453
Cesari, M., Kritchevsky, S. B., Baumgartner, R., Atkinson, H. H., Penninx, B. W. J. H., Lenchik, L., Palla, S. L., Ambrosius, W. T., Tracy, R. P., & Pahor, M. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn.82.2.428 · Cited by 422
Aging and Imaging Assessment of Body Composition: From Fat to Facts
Ponti, F., Santoro, A., Mercatelli, D., Gasperini, C., Conte, M., Martucci, M., Sangiorgi, L., Franceschi, C., & Bazzocchi, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00861 · Cited by 408
Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity
Wannamethee, S. G., & Atkins, J. L. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s002966511500169x · Cited by 404
Self-citationKim, T. N., Yang, S. J., Yoo, H. J., Lim, K. I., Kang, H. J., Song, W., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., et al. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.130 · Cited by 401 · cited 1×
“Kim et al.(66) 2009 Cross-sectional n 526 Korean Sarcopenic Obesity Study Men and women Aged ≥20 years DXA (ASM; SMI; % body fat) Women with sarcopenic obesity (identified using SMI) have three times the risk of MetS and non-sarcopenic obese had two times the risk of MetS compared with non-sarcopenic, non-obese partic…”
Skeletal muscle and mortality results from the InCHIANTI study
Cesari, M., Pahor, M., Lauretani, F., Zamboni, V., Bandinelli, S., Bernabei, R., Guralnik, J. M., & Ferrucci, L. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gln031 · Cited by 346 · cited 2×
“Sarcopenic obesity, based on high WC (>102 cm) and low MAMC (lowest quartile), showed a 55% increase in risk of mortality compared with non-sarcopenic, non-obese Cesari et al.(86) 2009 Prospective cohort (6-year follow-up) n 934 InCHIANTI Study Men and women Aged ≥ 65 years.”
Epidemiology and consequences of sarcopenia
Abellan Van Kan, G. (2009) · The Journal of nutrition, health and aging · doi:10.1007/s12603-009-0201-z · Cited by 344
Liu, P., Hao, Q., Hai, S., Wang, H., Cao, L., & Dong, B. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.04.007 · Cited by 331 · cited 2×
“A recent meta-analysis of six prospective cohort studies examined the association between sarcopenia and mortality, including 7367 community-dwelling older adults (31) .”
Batsis, J. A., Barre, L. K., Mackenzie, T. A., Pratt, S. I., Lopez‐Jimenez, F., & Bartels, S. J. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12260 · Cited by 330
Donini, L. M., Busetto, L., Bauer, J. M., Bischoff, S., Boirie, Y., Cederholm, T., Cruz-Jentoft, A. J., Dicker, D., Frühbeck, G., Giustina, A., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.11.024 · Cited by 326 · cited 1×
“tions and approaches to diagnose sarcopenic obesity(54).”
Wannamethee, S. G., Shaper, A. G., Lennon, L., & Whincup, P. H. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1339 · Cited by 307 · cited 2×
“Regional Heart Study) the risk of all-cause mortality was increased in sarcopenic obese individuals; those with a high waist circumference (>102 cm) and in the lowest quartile of midarm muscle circumference had a 55 % increase in mortality risk compared with non-sarcopenic, non-obese individuals over a follow-up perio…”
Self-citationSarcopenic-obesity and cardiovascular disease risk in the elderly
Stephen, W. C., & Janssen, I. (2009) · The Journal of nutrition, health and aging · doi:10.1007/s12603-009-0084-z · Cited by 301 · cited 7×
“Stephen & Janssen (79) 2009 (39) .”
InfluentialChung, J.-Y., Kang, H.-T., Lee, D.-C., Lee, H.-R., & Lee, Y.-J. (2013) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2012.09.007 · Cited by 283 · cited 1×
“Chung et al.(60) 2013 Cross-sectional n 2943 Korea National Health and Nutrition Examination Survey Men and women Aged ≥60 years DXA (ASM); BMI≥ 25 kg/m2 The sarcopenic obese group was associated with a higher risk of insulin resistance, MetS and CV risk factors than any other group Srco p en ic o b esity in aein g”
Tian, S., & Xu, Y. (2016) · Geriatrics & Gerontology International · doi:10.1111/ggi.12579 · Cited by 274
Chin, S. O., Rhee, S. Y., Chon, S., Hwang, Y.-C., Jeong, I.-K., Oh, S., Ahn, K. J., Chung, H. Y., Woo, J.-T., Kim, S.-W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060119 · Cited by 252
Hirani, V., Naganathan, V., Blyth, F., Le Couteur, D. G., Seibel, M. J., Waite, L. M., Handelsman, D. J., & Cumming, R. G. (2017) · Age and Ageing · doi:10.1093/ageing/afw214 · Cited by 246 · cited 2×
“Similarly, a recent small study in 954 men (aged 70 years and above, followed-up for over 7 years) from the Concord Health and Ageing in Men Project, categorised sarcopenic obesity based onDXA-measured leanmass and body fat, also found no significant association between sarcopenic obesity and mortality risk after adju…”
Livshits, G., & Kalinkovich, A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100980 · Cited by 237
Allison, D., Zhu, S., Plankey, M., Faith, M., & Heo, M. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801925 · Cited by 221 · cited 2×
“differentiate between fat mass and lean mass(13).”
Zhang, X., Xie, X., Dou, Q., Liu, C., Zhang, W., Yang, Y., Deng, R., & Cheng, A. S. K. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1195-y · Cited by 209 · cited 4×
“The pooled HR showed that sarcopenic obesity was associated with a 24 % increase in risk of all-cause mortality compared with the non-sarcopenic, non-obese group Zhang et al. (92) Meta-analysis n 50 866 Twenty-three prospective cohort studies Men and women 50 – 82 years”
InfluentialKim, T. N., Park, M. S., Lim, K. I., Choi, H. Y., Yang, S. J., Yoo, H. J., Kang, H. J., Song, W., Choi, H., Baik, S. H., et al. (2013) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04433.x · Cited by 208 · cited 2×
“Kim et al.(64) 2013 Cross-sectional n 493 Korean Sarcopenic Obesity Study Men and women Aged ≥20 years DXA (ASM); CT (VFA) In women, the sarcopenic obese group had higher levels of insulin resistance and CRP compared with the non-sarcopenic, obese group.”
Sarcopenic obesity is closely associated with metabolic syndrome
Lu, C.-W., Yang, K.-C., Chang, H.-H., Lee, L.-T., Chen, C.-Y., & Huang, K.-C. (2013) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2012.02.003 · Cited by 198 · cited 2×
“A study in Taiwanese older adults (defined by BIA-measured muscle mass and BMI) is also comparable in that the sarcopenia obese group also had the highest risk of the metabolic syndrome, with a 12 times increased risk, compared with the non-sarcopenic, non-obese group(67).”
Vetrano, D. L., Landi, F., Volpato, S., Corsonello, A., Meloni, E., Bernabei, R., & Onder, G. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu034 · Cited by 194
Waters, D. L., & Baumgartner, R. N. (2011) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2011.03.007 · Cited by 185 · cited 1×
“The operational definition of sarcopenic obesity is still under discussion (36) and hence there is no universally accepted classification (24,40,52) .”
Baek, S. J., Nam, G. E., Han, K. D., Choi, S. W., Jung, S. W., Bok, A. R., Kim, Y. H., Lee, K. S., Han, B. D., & Kim, D. H. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-013-0011-3 · Cited by 182
Physical Activity and Sarcopenic Obesity: Definition, Assessment, Prevalence and Mechanism
Lee, D.-C., Shook, R. P., Drenowatz, C., & Blair, S. N. (2016) · Future Science OA · doi:10.4155/fsoa-2016-0028 · Cited by 177 · cited 1×
“penia and obesity have varied significantly depending on population, age, sex and ethnicity(55).”
Zamboni, M., Rubele, S., & Rossi, A. P. (2019) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000519 · Cited by 173 · cited 1×
“The operational definition of sarcopenic obesity is still under discussion(36) and hence there is no universally accepted classification(24,40,52).”
Factors associated with sarcopenia: A cross-sectional analysis using UK Biobank
Petermann-Rocha, F., Chen, M., Gray, S. R., Ho, F. K., Pell, J. P., & Celis-Morales, C. (2020) · Maturitas · doi:10.1016/j.maturitas.2020.01.004 · Cited by 172
Sarcopenic obesity in aging population: current status and future directions for research
Kohara, K. (2014) · Endocrine · doi:10.1007/s12020-013-9992-0 · Cited by 171
de Hollander, E. L., Bemelmans, W. J., Boshuizen, H. C., Friedrich, N., Wallaschofski, H., Guallar-Castillon, P., Walter, S., Zillikens, M. C., Rosengren, A., Lissner, L., et al. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys008 · Cited by 162
Han, K., Park, Y.-M., Kwon, H.-S., Ko, S.-H., Lee, S.-H., Yim, H. W., Lee, W.-C., Park, Y. G., Kim, M. K., & Park, Y.-M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086902 · Cited by 158
Preventing sarcopaenia in older people
Visvanathan, R., & Chapman, I. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.03.020 · Cited by 144
Farmer, R. E., Mathur, R., Schmidt, A. F., Bhaskaran, K., Fatemifar, G., Eastwood, S. V., Finan, C., Denaxas, S., Smeeth, L., & Chaturvedi, N. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011638 · Cited by 144
Khadra, D., Itani, L., Tannir, H., Kreidieh, D., Masri, D. E., & Ghoch, M. E. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i5.311 · Cited by 130
Zhang, X., Wang, C., Dou, Q., Zhang, W., Yang, Y., & Xie, X. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-021252 · Cited by 127
Kim, J.-H., Cho, J. J., & Park, Y. S. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.3.264 · Cited by 126
Tyrovolas, S., Panagiotakos, D., Georgousopoulou, E., Chrysohoou, C., Tousoulis, D., Haro, J. M., & Pitsavos, C. (2020) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2019-212268 · Cited by 123
Timpka, S., Petersson, I. F., Zhou, C., & Englund, M. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-62 · Cited by 120
Sarcopenic obesity as an independent risk factor of hypertension
Park, S. H., Park, J. H., Song, P. S., Kim, D. K., Kim, K. H., Seol, S. H., Kim, H. K., Jang, H. J., Lee, J. G., Park, H. Y., et al. (2013) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2013.06.002 · Cited by 118
Sarcopenia and sarcopenic obesity
Choi, K. M. (2013) · Endocrinology and Metabolism · doi:10.3803/enm.2013.28.2.86 · Cited by 113
Stenholm, S., Mehta, N. K., Elo, I. T., Heliövaara, M., Koskinen, S., & Aromaa, A. (2014) · International Journal of Obesity · doi:10.1038/ijo.2013.214 · Cited by 111
Sarcopenic obesity, weight loss, and mortality: the english longitudinal study of ageing
Hamer, M., & O’Donovan, G. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.152488 · Cited by 110 · cited 2×
“Sarcopenic obesity, based on BIA, was not associated with mortality Hamer & O’Donovan(90) 2017 Prospective cohort (8·1-year followup) n 6864 English Longitudinal Study of Ageing Men and women Mean age 66·2 (SD 9·5) years Grip strength; BMI Sarcopenic obesity did not confer any greater risk of mortality than sarcopenia…”
The role of nutrition in the prevention of sarcopenia
Volkert, D. (2011) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-011-0910-x · Cited by 106
Spahillari, A., Mukamal, K. J., DeFilippi, C., Kizer, J. R., Gottdiener, J. S., Djoussé, L., Lyles, M. F., Bartz, T. M., Murthy, V. L., & Shah, R. V. (2016) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.06.011 · Cited by 104
Rossi, A. P., Bianchi, L., Volpato, S., Bandinelli, S., Guralnik, J., Zamboni, M., & Ferrucci, L. (2017) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glw203 · Cited by 97
Prevalence Rate and Associated Factors of Sarcopenic Obesity in Korean Elderly Population
Hwang, B., Lim, J.-Y., Lee, J., Choi, N.-K., Ahn, Y.-O., & Park, B.-J. (2012) · Journal of Korean Medical Science · doi:10.3346/jkms.2012.27.7.748 · Cited by 95
Sarcopenic obesity: research advances in pathogenesis and diagnostic criteria
Xie, W.-Q., Xiao, G.-L., Fan, Y.-B., He, M., Lv, S., & Li, Y.-S. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01435-9 · Cited by 86
Sarcopenia and sarcopenic obesity classifications and cardiometabolic risks in older women
dos Santos, E. P., Gadelha, A. B., Safons, M. P., Nóbrega, O. T., Oliveira, R. J., & Lima, R. M. (2014) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2014.03.012 · Cited by 69
Kim, T. N., Park, M. S., Kim, Y. J., Lee, E. J., Kim, M.-K., Kim, J. M., Ko, K. S., Rhee, B. D., & Won, J. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100118 · Cited by 64
Pescatori, L., Savarino, E. V., Mauri, G., Silvestri, E., Cariati, M., Sardanelli, F., & Sconfienza, L. M. (2019) · Radiologia Brasileira · doi:10.1590/0100-3984.2017.0211 · Cited by 59
Messier, V., Karelis, A. D., Lavoie, M.-E., Brochu, M., Faraj, M., Strychar, I., & Rabasa-Lhoret, R. (2009) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-135 · Cited by 54 · cited 3×
“Similar associations found in men although not significant Messier et al.(70) 2009 Cross-sectional n 136 Healthy overweight or obese postmenopausal women Aged 46–70 years DXA (ASM); CT Sarcopenic overweight/obese women did not show a higher risk metabolic profile compared with non-sarcopenic overweight/obese women”
Petermann-Rocha, F., Chen, M., Gray, S. R., Ho, F. K., Pell, J. P., & Celis-Morales, C. (2019) · Age and Ageing · doi:10.1093/ageing/afz126 · Cited by 53
(2019) · Elsevier eBooks · doi:10.1016/c2016-0-00256-5 · Cited by 39
Association between sarcopenic obesity and cardiovascular risk: where are we?
Sena, M. H. L. G., Curvello-Silva, K., Barreto-Medeiros, J. M., & Da-Cunha-Daltro, C. H. (2016) · Nutrición Hospitalaria · doi:10.20960/nh.592 · Cited by 34
Khadra, D., Itani, L., Chebaro, Y., Obeid, M., Jaber, M., Ghanem, R., Ayton, A. K., Kreidieh, D., Masri, D. E., Kimura, A., et al. (2020) · Current Cardiology Reviews · doi:10.2174/1573403x16666200214104122 · Cited by 24
The effect of sarcopenic obesity on cardiovascular disease and all-cause mortality in older people
Atkins, J. L., & Wannamethee, S. G. (2015) · Reviews in Clinical Gerontology · doi:10.1017/s0959259815000076 · Cited by 18
Self-citationSkeletal muscle morphology and risk of cardiovascular disease in elderly men
Andersen, K., Lind, L., Ingelsson, E., Ärnlöv, J., Byberg, L., Michaëlsson, K., & Sundström, J. (2013) · European Journal of Preventive Cardiology · doi:10.1177/2047487313506828 · Cited by 12
Effects of Sarcopenic Obesity on Cardiovascular Disease and All-Cause Mortality
Atkins, J. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-810422-4.00007-5 · Cited by 11
Self-citationTorjesen, I. (2007) · PubMed · Cited by 3
Research works printed but not linked: 2
- 2011, Healthy Lives, Healthy People: A Call to Action on Obesity in England
- 10.1093/ajcn/82.2.428 · DOI · Paper page
Cited by
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Obesity Facts · doi:10.1159/000521241 · Cited by 1,019
Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2021.11.014 · Cited by 566
Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management
Wei, S., Nguyen, T. T., Zhang, Y., Ryu, D., & Gariani, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1185221 · Cited by 291
Ten things to know about ten cardiovascular disease risk factors
Bays, H. E., Taub, P. R., Epstein, E., Michos, E. D., Ferraro, R. A., Bailey, A. L., Kelli, H. M., Ferdinand, K. C., Echols, M. R., Weintraub, H., et al. (2021) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2021.100149 · Cited by 274
Sarcopenia and Sarcopenic Obesity and Mortality Among Older People
Benz, E., Pinel, A., Guillet, C., Capel, F., Pereira, B., De Antonio, M., Pouget, M., Cruz-Jentoft, A. J., Eglseer, D., Topinkova, E., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.3604 · Cited by 261
Metadata
- Authors
- Atkins, J. L., & Wannamathee, S. G.
- Affiliations
- University of Exeter (GB)
- Corresponding author
- Atkins, Janice L.
- ORCID
- Atkins, Janice L.
- Venue
- British Journal of Nutrition
- Publisher
- Cambridge University Press (CUP)
- Published
- 2020-06-18
- Volume
- 124
- Issue
- 10
- Pages
- 1102-1113
- ISSN
- 0007-1145 (ISSN-L)
- 1475-2662
- OpenAlex
- W3036595750
- Cited by
- 187
- References
- 91
- Citations by year
- 2026: 16 · 2025: 39 · 2024: 42 · 2023: 36 · 2022: 30 · 2021: 21 · 2020: 2
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- British Journal Of Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute for Health and Care Research (SPCR-031)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Keywords
- sarcopenic obesity, sarcopenia, aging, cardiovascular disease, mortality, obesity paradox, body mass index, visceral fat, lean body mass, muscle mass, older adults, adiposity
- MeSH terms
- Aged, Aged, 80 and over, Aging, Body Composition, Cardiovascular Diseases, Female, Humans, Inflammation, Male, Middle Aged, Obesity, Risk Factors, Body Mass Index, Adiposity, Overweight, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.